Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Oral contraceptive pills: A risk factor for retinal vascular occlusion in in-vitro fertilization patients.

Aggarwal RS, Mishra VV, Aggarwal SV.

J Hum Reprod Sci. 2013 Jan;6(1):79-81. doi: 10.4103/0974-1208.112389.

2.
3.

Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.

Ding X, Li J, Hu X, Yu S, Pan J, Tang S.

Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.

PMID:
21293319
4.

Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.

Gewaily D, Muthuswamy K, Greenberg PB.

Cochrane Database Syst Rev. 2015 Sep 9;(9):CD007324. doi: 10.1002/14651858.CD007324.pub3. Review.

5.

Unilateral macular edema with central retinal vein occlusion in systemic lupus erythematosus: a case report.

Noma H, Shimizu H, Mimura T.

Clin Ophthalmol. 2013;7:865-7. doi: 10.2147/OPTH.S44341. Epub 2013 May 9.

6.

[Treatment modalities in central retinal vein occlusion].

Masoud M, Siman-Tov S, Ibrahim A, Pikkel J.

Harefuah. 2010 Apr;149(4):245-50, 261, 260. Review. Hebrew.

PMID:
20812500
7.

Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion.

Gokce G, Sobaci G, Durukan AH, Erdurman FC.

Postgrad Med. 2013 Sep;125(5):51-8. doi: 10.3810/pgm.2013.09.2699.

PMID:
24113663
8.

Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.

Mitry D, Bunce C, Charteris D.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009510. doi: 10.1002/14651858.CD009510.pub2. Review.

PMID:
23440840
9.

Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion.

Kim JY, Park SP.

Korean J Ophthalmol. 2009 Dec;23(4):259-65. doi: 10.3341/kjo.2009.23.4.259. Epub 2009 Dec 4.

10.

Systemic diseases associated with various types of retinal vein occlusion.

Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P.

Am J Ophthalmol. 2001 Jan;131(1):61-77.

PMID:
11162981
11.

Potential anti-vascular endothelial growth factor therapies for central retinal vein occlusion.

Figueroa MS, Contreras I.

Drugs. 2012 Nov 12;72(16):2063-71. doi: 10.2165/11640820-000000000-00000.

PMID:
23061805
12.

[The eye and hormones: vascular disorders associated with combined oral contraceptives and pregnancy].

Villatte-cathelineau B.

Contracept Fertil Sex (Paris). 1985 Jan;13(1 Suppl):147-52. French.

PMID:
12280201
13.

Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma.

Higashide T, Murotani E, Saito Y, Ohkubo S, Sugiyama K.

Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):603-10. doi: 10.1007/s00417-011-1865-8. Epub 2011 Nov 25.

PMID:
22116499
14.

Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.

CekiƧ O, Chang S, Tseng JJ, Barile GR, Weissman H, Del Priore LV, Schiff WM, Weiss M, Klancnik JM Jr.

Retina. 2005 Oct-Nov;25(7):846-50.

PMID:
16205562
15.

Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis.

Zhou S, Gao J, Xu X.

Clin Exp Ophthalmol. 2014 Sep-Oct;42(7):637-49. doi: 10.1111/ceo.12286. Epub 2014 Jan 27.

PMID:
24330277
16.

Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.

Sonoda Y, Arimura N, Shimura M, Sakamoto T.

Retina. 2011 Feb;31(2):290-7. doi: 10.1097/IAE.0b013e3181eef070.

PMID:
21102366
17.

[Aging and retinal vascular diseases].

Takagi H.

Nippon Ganka Gakkai Zasshi. 2007 Mar;111(3):207-30; discussion 231. Review. Japanese.

PMID:
17402563
18.

Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.

Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Hartnett ME, Cohen G; Standard Care versus COrticosteroid for REtinal Vein Occlusion Study Investigator Group..

Ophthalmology. 2011 Feb;118(2):345-52. doi: 10.1016/j.ophtha.2010.06.034.

19.
20.

Retinal vein thrombosis: pathogenesis and management.

Rehak M, Wiedemann P.

J Thromb Haemost. 2010 Sep;8(9):1886-94. doi: 10.1111/j.1538-7836.2010.03909.x. Review.

Supplemental Content

Support Center